Theophylline
NDC 0480-3309, Theophylline, tablet, extended release, from Teva Pharmaceuticals, Inc..
- Product NDC
- 0480-3309
- Status
- Listed
- Labeler
- Teva Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216961
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3309 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE450 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0480-3309-01 | 00480330901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0480-3309-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/25eabefa-518b-4030-9b72-01ac8b3deba9NADAC price for package 00480330901
GET /v1/drugs/nadac/00480330901
Use it
Look up 0480-3309 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3309 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0480-3309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.